EDITOR
Neil Love, MD

TOPICS

Adjuvant Therapy of Early Breast Cancer

• Adjuvant chemotherapy for patients with node-negative tumors:
  Role of Oncotype DX™
• Docetaxel/cyclophosphamide (TC) versus AC
• Management of HER2-postive early breast cancer
• Long-term management of estrogen receptor-positive early breast cancer
  - Select publications

Management of Metastatic Disease

• Front-line management of HER2-positive metastatic disease
• HER2-directed therapy after progression on primary trastuzumab
• Combining bevacizumab with chemotherapy in the metastatic setting
  - Select publications

FACULTY

Howard A Burris III, MD Harold J Burstein, MD, PhD Melody A Cobleigh, MD William J Gradishar, MD Frankie A Holmes, MD Joyce O’Shaughnessy, MD

Peter M Ravdin, MD, PhD Lee S Schwartzberg, MD Andrew D Seidman, MD Dennis J Slamon, MD, PhD George W Sledge Jr, MD

Breast Cancer Update:
A CME Audio Series and Activity

Editor's Office | Faculty Disclosures